Atea Pharmaceuticals subleases Boston HQ; monthly rent $65,790 starting Jan 2022

Atea Pharmaceuticals, Inc.

Sublease 17,544 sq ft at 225 Franklin St, Boston; term Jan 1, 2022 to Dec 31, 2026.
Base rent $65,790/month (year 1), increasing 2% annually; plus operating expenses and taxes.
Sublandlord DataRobot provides $877,200 leasehold improvement allowance.
Existing lease at 125 Summer St expires July 2022; new space to be principal executive offices.
Sublease conditioned on Prime Landlord consent and continued existence of prime lease.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.